130 related articles for article (PubMed ID: 17542751)
1. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.
Sant AJ; Chaves FA; Krafcik FR; Lazarski CA; Menges P; Richards K; Weaver JM
Expert Rev Vaccines; 2007 Jun; 6(3):357-68. PubMed ID: 17542751
[TBL] [Abstract][Full Text] [Related]
2. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
3. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
Richards KA; Topham D; Chaves FA; Sant AJ
J Immunol; 2010 Nov; 185(9):4998-5002. PubMed ID: 20889549
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
6. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
7. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
[TBL] [Abstract][Full Text] [Related]
10. CD8+ regulatory T cells in persistent human viral infections.
Billerbeck E; Thimme R
Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
12. Induction of alphadelta- and alphabeta-mediated T cell responses in healthy elderly subjects after influenza vaccination.
Re F; Donnini A; Provinciali M
Biogerontology; 2006 Aug; 7(4):249-59. PubMed ID: 16821115
[TBL] [Abstract][Full Text] [Related]
13. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
[TBL] [Abstract][Full Text] [Related]
14. Killer T cells in influenza.
Stambas J; Guillonneau C; Kedzierska K; Mintern JD; Doherty PC; La Gruta NL
Pharmacol Ther; 2008 Nov; 120(2):186-96. PubMed ID: 18801385
[TBL] [Abstract][Full Text] [Related]
15. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis.
Markovic-Plese S; Hemmer B; Zhao Y; Simon R; Pinilla C; Martin R
J Neuroimmunol; 2005 Dec; 169(1-2):31-8. PubMed ID: 16150497
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
17. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells.
Lucas M; Day CL; Wyer JR; Cunliffe SL; Loughry A; McMichael AJ; Klenerman P
J Virol; 2004 Jul; 78(13):7284-7. PubMed ID: 15194806
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic human CD4(+) T cells.
van de Berg PJ; van Leeuwen EM; ten Berge IJ; van Lier R
Curr Opin Immunol; 2008 Jun; 20(3):339-43. PubMed ID: 18440213
[TBL] [Abstract][Full Text] [Related]
20. Th1 memory: implications for vaccine development.
Foulds KE; Wu CY; Seder RA
Immunol Rev; 2006 Jun; 211():58-66. PubMed ID: 16824117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
